8-K filed November 8, 2024, 6:59 PM ET ticker APYX CIK 0000719135

earnings confidence high sentiment negative materiality 0.85

Apyx Medical Q3 revenue down 4% to $11.5M; cuts FY24 guidance; workforce –25%

Apyx Medical Corp

Net loss $4.7M ($0.14/share) vs $4.6M YoY; adjusted EBITDA loss $2.4M.
Total revenue $11.5M (Advanced Energy -6% to $9.3M; OEM +3% to $2.2M).
FY24 revenue guidance cut to $46.6-47.6M from prior $50.6-52.1M; net loss expected ~$25M.
Raised ~$7M via registered direct offering of 3M shares + pre-funded warrants at $1.18/share.
Reduced U.S. workforce ~25% for ~$4.3M annual savings; three directors resigned; COO appointed.

item 1.01 item 2.02 item 2.03 item 3.02 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael Geraghty

Director

APYX · Apyx Medical Corp

Effective: 2024-11-04
Filed: November 8, 2024, 6:59 PM ET

On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.

Departed

John Andres

Director

APYX · Apyx Medical Corp

Effective: 2024-11-04
Filed: November 8, 2024, 6:59 PM ET

On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.

Appointed

Shawn D. Roman

Chief Operating Officer

APYX · Apyx Medical Corp

Effective: 2024-11-06
Filed: November 8, 2024, 6:59 PM ET

On November 6, 2024, the Board appointed Shawn D. Roman as the Chief Operating Officer of the Company, effective immediately.

Departed

Craig Swandal

Director

APYX · Apyx Medical Corp

Effective: 2024-11-04
Filed: November 8, 2024, 6:59 PM ET

On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Geraghty resigned as Director at Apyx Medical Corp.

Action: resigned
Role: Director

Exact text from the filing

On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

John Andres resigned as Director at Apyx Medical Corp.

Action: resigned
Role: Director

Exact text from the filing

On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Shawn D. Roman was appointed as Chief Operating Officer at Apyx Medical Corp.

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On November 6, 2024, the Board appointed Shawn D. Roman as the Chief Operating Officer of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Craig Swandal resigned as Director at Apyx Medical Corp.

Action: resigned
Role: Director

Exact text from the filing

On November 4, 2024, John Andres, Michael Geraghty, and Craig Swandal resigned from the Board of Directors, with such resignations effective immediately.

View on SEC.gov

Apyx Medical Corp filing history →

Source: SEC EDGAR

accession 0001493152-24-044154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.